Guidelines: Prescribing intravenous immunoglobulin: Summary of Department of Health guidelines

BMJ

Volumn 337, Issue 7676, 2008, Pages 990-992

  Provan, Drew ^a   Chapel, Helen M ^b   Sewell, W A Carrock ^c   O'Shaughnessy, Denise ^d  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c SCUNTHORPE GENERAL HOSPITAL   (United Kingdom)

^d Blood Policy Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

AUTOIMMUNE DISEASE; DRUG INDICATION; DRUG INDUSTRY; HEALTH CARE ORGANIZATION; HUMAN; IMMUNE DEFICIENCY; INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY; SYSTEMATIC REVIEW; ARTICLE; CLINICAL PRACTICE; HEALTH CARE PLANNING; UNITED KINGDOM;

GREAT BRITAIN; HEALTH PRIORITIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 55549113904     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a1831     Document Type: Short Survey

References (7)

1. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-55.
2. Boulis A, Goold S, Ubel PA. Responding to the immunoglobulin shortage: a case study. J Health Polit Policy Law 2002;27:977-99.
3. Pendergrast JM, Sher GD, Callum JL. Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995-2000. Vox Sang 2005;89:150-60.
4. Darabi K, Abdel-Wahab O, Dzik WH. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion 2006;46:741-53.
5. Provan D, Nokes TJC, Agrawal S, Winer J, Wood P, IVIg Guideline Development Group of the IVIg Expert Working Group. Clinical guidelines for immunoglobulin use. 2nd ed. London: Department of Health, 2008. www.ivig.nhs.uk/documents/Clinical%20Guidelines%20SECOND%20EDITION%20(3).pdf
6. US Department of Health and Human Services, Agency for Health Care Policy and Research. Clinical practice guideline No 1: acute pain management: operative or medical procedures and trauma. Rockville, MD: US Department of Health and Human Services, Agency for Health Care Policy and Research, 1993. (AHCPR publication No 92-0023.)
7. Department of Health. Demand management plan for immunoglobulin use. 2nd ed. London: DoH, 2008. www.ivig.nhs.uk/documents/ Demand_Management_Plan_SECOND_EDITION.pdf